Dupixent
Connecting law firms with patients who developed serious eye conditions after taking Dupixent.
Case Overview
Dupixent (Dupilumab) is a biologic medication approved to treat moderate-to-severe eczema (atopic dermatitis), asthma, chronic rhinosinusitis with nasal polyps. While marketed as a breakthrough treatment, Dupixent has been linked to serious eye problems.
Studies show that up to 30% of Dupixent users, particularly those with a history of atopic dermatitis and chronic inflammation, have experienced more severe conditions including keratitis (corneal inflammation), blepharitis, and even vision impairment.
Lawsuits allege that manufacturers Sanofi and Regeneron failed to adequately warn patients and doctors about the risk and severity of these eye problems.
Conjunctivitis, keratitis, blepharitis, vision problems
We identify patients with documented medical use and qualifying eye conditions.
Clinical studies and post-market reports have documented significant eye-related side effects.
Up to 30% of patients in clinical have developed conjunctivitis, far higher than the general population rate.
Inflammation of the cornea can lead to pain, light sensitivity, and potentially permanent vision damage.
Some patients have reported blurred vision, eye pain, and in severe cases, vision impairment.
We specialize in identifying qualified pharmaceutical injury claimants.
We reach inactive and actions patients who have been prescribed Dupixent through targeted campaigns.
Our intake process verifies prescription use and documents eye condition diagnoses.
Get ahead of this emerging litigation with qualified cases before the market becomes saturated.
Key Facts
- Drug: Dupixent (Dupilumab)
- Primary Injuries: Conjunctivitis, keratitis, blepharitis, vision problems
- Manufacturer: Sanofi, Regeneron Pharmaceuticals
- Litigation Status: Emerging – Cases now filed
Who Qualifies
Drug Usage
- Was Dupixent for eczema/atopic dermatitis
- Took Dupixent for asthma
- Took Dupixent for chronic rhinosinusitis
- Any Dupixent use leading to eye problems
Eye Conditions
- Conjunctivitis (pink eye)
- Keratitis (corneal inflammation)
- Blepharitis (eyelid inflammation)
- Dry eye syndrome
- Vision impairment or loss
Timing
- Eye problems developed after starting Dupixent
- No prior history of the eye condition
- Symptoms ongoing or required treatment
Documentation
- Prescription records for Dupixent
- Medical records documenting eye condition
- Eye doctor visit records
- Treatment records for eye condition
Interested in This Case?
Let's discuss how we can help you acquire qualified leads for this mass tort campaign.